|
|
Volumn 5, Issue 11, 2008, Pages 623-
|
|
The era of personalized medicine: Back to basics
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
IMATINIB;
K RAS PROTEIN;
PANITUMUMAB;
ADJUVANT THERAPY;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG EFFICACY;
DRUG PROTEIN BINDING;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG TARGETING;
EDITORIAL;
GENE MUTATION;
GENE TARGETING;
HUMAN;
LUNG NON SMALL CELL CANCER;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS AS TOPIC;
COLORECTAL NEOPLASMS;
DRUG DELIVERY SYSTEMS;
DRUG RESISTANCE, NEOPLASM;
GENE TARGETING;
GENES, ERBB-1;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
LUNG NEOPLASMS;
PATIENT-CENTERED CARE;
PIPERAZINES;
PYRIMIDINES;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 55549130297
PISSN: 17434254
EISSN: 17434262
Source Type: Journal
DOI: 10.1038/ncponc1253 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|